CervoMed (CRVO) Preferred Shares (2010 - 2022)
CervoMed (CRVO) posted Preferred Shares of $5000.0 for Q1 2022, up 55455.56% sequentially from $9.0 in Q1 2013.
CervoMed (CRVO) Preferred Shares (2010 - 2022) Analysis & Trends
CervoMed has reported Preferred Shares for 5 years, with the latest figure at $5000.0 in Q1 2022.
- Quarterly Preferred Shares changed N/A year-over-year to $5000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $5000.0 (changed N/A YoY) and the FY2012 annual result came in at $19.0, up 111.11% from the prior year.
- Preferred Shares grew to $5000.0 in Q1 2022 per CRVO's latest filing, from $9.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $5000.0 in Q1 2022 and troughed at $5000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 5,000.00 |
| Mar 31, 2013 | 9.00 |
| Dec 31, 2012 | 19.00 |
| Sep 30, 2012 | 8.00 |
| Mar 31, 2012 | 19.00 |
| Dec 31, 2011 | 9.00 |
| Sep 30, 2011 | 9.00 |
| Jun 30, 2011 | 9.00 |
| Dec 31, 2010 | 18.00 |